<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(4)</volume><submitter>Otten MH</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To investigate neurocognitive, psychosocial, and quality of life (QoL) outcomes in children with Multisystem Inflammatory Syndrome in Children (MIS-C) seen 3-6 months after PICU admission.&lt;h4>Design&lt;/h4>National prospective cohort study March 2020 to November 2021.&lt;h4>Setting&lt;/h4>Seven PICUs in the Netherlands.&lt;h4>Patients&lt;/h4>Children with MIS-C (0-17 yr) admitted to a PICU.&lt;h4>Interventions&lt;/h4>None.&lt;h4>Measurements and main results&lt;/h4>Children and/or parents were seen median (interquartile range [IQR] 4 mo [3-5 mo]) after PICU admission. Testing included assessment of neurocognitive, psychosocial, and QoL outcomes with reference to Dutch pre-COVID-19 general population norms. Effect sizes (Hedges' g ) were used to indicate the strengths and clinical relevance of diff</pubmed_abstract><journal>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</journal><pagination>289-300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10072052</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU.</pubmed_title><pmcid>PMC10072052</pmcid><pubmed_authors>Otten MH</pubmed_authors><pubmed_authors>Roeleveld PP</pubmed_authors><pubmed_authors>Kneyber MCJ</pubmed_authors><pubmed_authors>Buddingh EP</pubmed_authors><pubmed_authors>van Schooneveld M</pubmed_authors><pubmed_authors>Buysse CMP</pubmed_authors><pubmed_authors>Humblet M</pubmed_authors><pubmed_authors>Walker JC</pubmed_authors><pubmed_authors>von Asmuth EGJ</pubmed_authors><pubmed_authors>Ketharanathan N</pubmed_authors><pubmed_authors>Krabben G</pubmed_authors><pubmed_authors>van Woensel JBM</pubmed_authors><pubmed_authors>Hogenbirk K</pubmed_authors><pubmed_authors>Wassenberg R</pubmed_authors><pubmed_authors>van Zwol A</pubmed_authors><pubmed_authors>Dulfer K</pubmed_authors><pubmed_authors>Maebe S</pubmed_authors><pubmed_authors>van Waardenburg D</pubmed_authors><pubmed_authors>Maas NM</pubmed_authors><pubmed_authors>de Wit E</pubmed_authors><pubmed_authors>de Hoog M</pubmed_authors><pubmed_authors>Terheggen-Lagro SWJ</pubmed_authors><pubmed_authors>Haverman L</pubmed_authors><pubmed_authors>Timmers-Raaijmaakers B</pubmed_authors><pubmed_authors>Oostrom KJ</pubmed_authors><pubmed_authors>Joosten KFM</pubmed_authors><pubmed_authors>de Sonnaville ESV</pubmed_authors><pubmed_authors>Bunker-Wiersma HE</pubmed_authors><pubmed_authors>Knoester H</pubmed_authors><pubmed_authors>Lemson J</pubmed_authors><pubmed_authors>Wolthuis DW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neurocognitive, Psychosocial, and Quality of Life Outcomes After Multisystem Inflammatory Syndrome in Children Admitted to the PICU.</name><description>&lt;h4>Objectives&lt;/h4>To investigate neurocognitive, psychosocial, and quality of life (QoL) outcomes in children with Multisystem Inflammatory Syndrome in Children (MIS-C) seen 3-6 months after PICU admission.&lt;h4>Design&lt;/h4>National prospective cohort study March 2020 to November 2021.&lt;h4>Setting&lt;/h4>Seven PICUs in the Netherlands.&lt;h4>Patients&lt;/h4>Children with MIS-C (0-17 yr) admitted to a PICU.&lt;h4>Interventions&lt;/h4>None.&lt;h4>Measurements and main results&lt;/h4>Children and/or parents were seen median (interquartile range [IQR] 4 mo [3-5 mo]) after PICU admission. Testing included assessment of neurocognitive, psychosocial, and QoL outcomes with reference to Dutch pre-COVID-19 general population norms. Effect sizes (Hedges' g ) were used to indicate the strengths and clinical relevance of diff</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T10:41:36.631Z</modification><creation>2025-04-04T10:41:36.631Z</creation></dates><accession>S-EPMC10072052</accession><cross_references><pubmed>36688688</pubmed><doi>10.1097/PCC.0000000000003180</doi></cross_references></HashMap>